ALPN vs. RXST
Compare and contrast key facts about Alpine Immune Sciences, Inc. (ALPN) and RxSight, Inc. (RXST).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ALPN or RXST.
Key characteristics
| ALPN | RXST | |
|---|---|---|
| YTD Return | 238.93% | 52.98% |
| 1Y Return | 844.44% | 240.40% |
| Sharpe Ratio | 9.84 | 4.12 |
| Daily Std Dev | 83.73% | 55.12% |
| Max Drawdown | -97.33% | -48.21% |
| Current Drawdown | -19.89% | 0.00% |
Fundamentals
| ALPN | RXST | |
|---|---|---|
| Market Cap | $4.24B | $2.29B |
| EPS | -$0.64 | -$1.41 |
| PEG Ratio | 0.00 | 3.86 |
| Revenue (TTM) | $58.88M | $89.08M |
| Gross Profit (TTM) | -$40.18M | $21.33M |
| EBITDA (TTM) | -$43.67M | -$46.01M |
Correlation
The correlation between ALPN and RXST is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ALPN vs. RXST - Performance Comparison
In the year-to-date period, ALPN achieves a 238.93% return, which is significantly higher than RXST's 52.98% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ALPN vs. RXST - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Alpine Immune Sciences, Inc. (ALPN) and RxSight, Inc. (RXST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ALPN vs. RXST - Dividend Comparison
Neither ALPN nor RXST has paid dividends to shareholders.
Drawdowns
ALPN vs. RXST - Drawdown Comparison
The maximum ALPN drawdown since its inception was -97.33%, which is greater than RXST's maximum drawdown of -48.21%. Use the drawdown chart below to compare losses from any high point for ALPN and RXST. For additional features, visit the drawdowns tool.
Volatility
ALPN vs. RXST - Volatility Comparison
Alpine Immune Sciences, Inc. (ALPN) has a higher volatility of 36.52% compared to RxSight, Inc. (RXST) at 16.51%. This indicates that ALPN's price experiences larger fluctuations and is considered to be riskier than RXST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ALPN vs. RXST - Financials Comparison
This section allows you to compare key financial metrics between Alpine Immune Sciences, Inc. and RxSight, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities